| | | | | |
GHRS GH Research PLC Ordinary Shares | €19,8763 | +4,52% | €1,27B | €259,17K | |
GBX The Greenbrier Companies, Inc. | €41,5235 | +0,75% | €1,27B | €267,66K | |
| €32,7030 | -0,16% | €1,27B | €242,21K | |
QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund - Shares of Beneficial Interest | €26,5905 | +0,95% | €1,27B | €77,65K | |
CBL CBL & Associates Properties, Inc. | €40,5692 | -0,08% | €1,26B | €271,06K | |
| €6,3274 | -5,76% | €1,26B | €11,39M | |
MBX MBX Biosciences, Inc. Common Stock | €27,2869 | -0,35% | €1,26B | €212,84K | |
URGN UroGen Pharma Ltd. Ordinary Shares | €25,2924 | +1,84% | €1,26B | €515,85K | |
| €24,7852 | +1,91% | €1,26B | €963,45K | |
NVGS NAVIGATOR HOLDINGS LTD. | €20,0396 | +0,78% | €1,26B | €420,49K | |
CMPS COMPASS Pathways Plc American Depository Shares | €10,5098 | +3,51% | €1,26B | €3,28M | |
| €41,4032 | +1,78% | €1,25B | €100,62K | |
ARI APOLLO COMMERCIAL REAL ESTATE FINANCE, INC. | €9,4911 | +0,91% | €1,25B | €1,27M | |
| €8,7775 | -0,58% | €1,25B | €957,04K | |
| €32,0496 | +1,72% | €1,25B | €294,73K | |
